Mostrar el registro sencillo del ítem

dc.contributor.authorGuinea, Jesús
dc.contributor.authorRecio, Sandra
dc.contributor.authorEscribano, Pilar
dc.contributor.authorPelaez, Teresa
dc.contributor.authorGama, Beatriz
dc.contributor.authorBouza, Emilio
dc.date.accessioned2024-02-06T10:13:52Z
dc.date.available2024-02-06T10:13:52Z
dc.date.issued2010-06-21
dc.identifier.citationGuinea, J., Recio, S., Escribano, P., Peláez, T., Gama, B., & Bouza, E. (2010). In vitro antifungal activities of isavuconazole and comparators against rare yeast pathogens. Antimicrobial agents and chemotherapy, 54(9), 4012–4015. https://doi.org/10.1128/AAC.00685-10es
dc.identifier.issn0066-4804
dc.identifier.otherhttps://journals.asm.org/journal/aaces
dc.identifier.urihttp://hdl.handle.net/20.500.12020/1222
dc.description.abstractWe compared the in vitro activities of isavuconazole, posaconazole, voriconazole, and fluconazole against Dipodascus capitatus (n = 21), Saccharomyces cerevisiae (n = 20), Rhodotorula mucilaginosa (n = 18), and Trichosporon spp. (n = 15). The MIC(50)s, MIC(90)s, and MIC ranges (in microg/ml) obtained using the CLSI M27-A3 procedure were as follows: isavuconazole, 0.125, 0.5, and < or = 0.015 to 2; posaconazole, 0.5, 2, and < or = 0.015 to > 16; voriconazole, 0.125, 2, and < or = 0.015 to 8; and fluconazole, 4, > 128, and < or = 0.125 to > 128. Isavuconazole showed potent activity against the isolates studiedes
dc.language.isoenes
dc.publisherAmerican Society for Microbiologyes
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleIn Vitro Antifungal Activities of Isavuconazole and Comparators against Rare Yeast Pathogenses
dc.typearticlees
dc.identifier.doi10.1128/AAC.00685-10
dc.issue.number9es
dc.journal.titleAntimicrobial Agents and Chemotherapyes
dc.page.initial4012es
dc.page.final4015es
dc.relation.projectIDThis study was partially financed by grants from Basilea Pharmaceutica International Ltd. and by grants from the Fondo de Investigacio´n Sanitaria (FIS) PI070198 (Instituto de Salud Carlos III).es
dc.rights.accessRightsembargoedAccesses
dc.subject.areaCiencias Biomédicases
dc.subject.keywordCandidaes
dc.subject.keywordIsavuconazolees
dc.subject.keywordAntifungal activityes
dc.subject.keywordNon-candidaes
dc.subject.keywordCandidemiaes
dc.subject.keywordYeastses
dc.subject.keywordAntifungal activityes
dc.subject.unesco2414 Microbiologíaes
dc.volume.number54es


Ficheros en el ítem

Fichero/sTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional